JP2007509847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509847A5 JP2007509847A5 JP2006535596A JP2006535596A JP2007509847A5 JP 2007509847 A5 JP2007509847 A5 JP 2007509847A5 JP 2006535596 A JP2006535596 A JP 2006535596A JP 2006535596 A JP2006535596 A JP 2006535596A JP 2007509847 A5 JP2007509847 A5 JP 2007509847A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- independently
- group
- alkyl
- haloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 CC(C)(*)C(*)N(C)C Chemical compound CC(C)(*)C(*)N(C)C 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51145703P | 2003-10-14 | 2003-10-14 | |
| US60/511,457 | 2003-10-14 | ||
| PCT/US2004/033666 WO2005037755A2 (en) | 2003-10-14 | 2004-10-13 | Bridged ring structures as pharmaceutical agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509847A JP2007509847A (ja) | 2007-04-19 |
| JP2007509847A5 true JP2007509847A5 (https=) | 2007-11-29 |
| JP4782688B2 JP4782688B2 (ja) | 2011-09-28 |
Family
ID=34465234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006535596A Expired - Fee Related JP4782688B2 (ja) | 2003-10-14 | 2004-10-13 | 医薬品としての架橋環構造 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7863298B2 (https=) |
| EP (1) | EP1675812B1 (https=) |
| JP (1) | JP4782688B2 (https=) |
| AT (1) | ATE455749T1 (https=) |
| AU (1) | AU2004282162B2 (https=) |
| CA (1) | CA2542650C (https=) |
| DE (1) | DE602004025261D1 (https=) |
| WO (1) | WO2005037755A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1511740T1 (sl) * | 2002-05-29 | 2009-12-31 | Lilly Co Eli | Modulatorji vitamin d receptorja tipa fenil-tiofen |
| ES2291981T3 (es) * | 2003-11-20 | 2008-03-01 | Eli Lilly And Company | Moduladores del receptor de la vitamina d. |
| CA2544857A1 (en) * | 2003-11-20 | 2005-06-09 | Eli Lilly And Company | Vitamin d receptor modulators |
| TW200600494A (en) * | 2004-03-08 | 2006-01-01 | Chugai Pharmaceutical Co Ltd | Bisphenyl compounds useful as vitamin d3 receptor agonists |
| US7825265B2 (en) | 2004-05-04 | 2010-11-02 | Acadia Pharmaceuticals Inc. | Compounds with activity at estrogen receptors |
| TW200716536A (en) | 2005-06-09 | 2007-05-01 | Chugai Pharmaceutical Co Ltd | Vitamin D compounds |
| WO2009114540A2 (en) * | 2008-03-10 | 2009-09-17 | Wisconsin Alumni Research Foundation | Vitamin d compounds and methods for reducing ocular hypertension (oht) |
| WO2010082837A1 (en) * | 2009-01-16 | 2010-07-22 | Jan Anne Lyftogt | Medicament for the treatment of pain and inflammation |
| CA2981549A1 (en) | 2009-01-27 | 2010-08-05 | Berg Llc | Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| CN106265695B (zh) | 2009-08-14 | 2021-05-07 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
| JP5375502B2 (ja) * | 2009-10-06 | 2013-12-25 | 信越化学工業株式会社 | アルコール性水酸基含有化合物及びその製造方法 |
| CN112156097A (zh) | 2013-05-29 | 2021-01-01 | 博格有限责任公司 | 使用维生素d预防或减轻化疗诱发的脱发 |
| US10751315B2 (en) | 2017-08-29 | 2020-08-25 | National Jewish Health | Methods and compositions for treating infection and inflammation with selenocyanate |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1543908A1 (de) | 1966-07-05 | 1970-01-02 | Stecker Chemicals Inc | Verfahren zur Herstellung von keimtoetend wirkenden,durch zwei Fluormethylgruppen substituierten Methylen-bisphenolen |
| JPS4931651A (https=) | 1972-07-20 | 1974-03-22 | ||
| US4717760A (en) * | 1986-07-10 | 1988-01-05 | The Dow Chemical Company | Fluorinated tris-epoxides based on triphenyl methane |
| EP0285160B1 (en) * | 1987-04-03 | 1993-12-08 | Daikin Industries, Limited | Fluorine-containing aromatic compound, process for preparing the same and use thereof |
| DE3879113D1 (de) | 1987-11-24 | 1993-04-15 | Hoechst Ag | Teilfluorierte carbonsaeuren sowie derivate davon, verfahren zu ihrer herstellung und verwendung. |
| DE4001932A1 (de) | 1990-01-24 | 1991-07-25 | Bayer Ag | 1,1-bicyclo-substituierte fluorhaltige cyclopentane und verfahren zu deren herstellung |
| JPH03255067A (ja) | 1990-03-05 | 1991-11-13 | Nitto Denko Corp | 含フッ素ビスマレイミド及びその製造方法 |
| US5210353A (en) * | 1990-11-30 | 1993-05-11 | Amoco Corporation | Aromatic transformation process |
| JP2784882B2 (ja) * | 1994-04-28 | 1998-08-06 | 第一工業製薬株式会社 | 粉末状高融点２，２−ビス［４′−（２″，３″−ジブロモプロポキシ）−３′，５′−ジブロモフェニル］プロパンの製造方法 |
| US6218430B1 (en) * | 1998-08-24 | 2001-04-17 | Ligand Pharmaceuticals Incorporated | Vitamin D3 mimics |
| EP1535610A4 (en) | 2002-06-10 | 2008-12-31 | Inst Med Molecular Design Inc | THERAPEUTIC CANCER |
| US20060035944A1 (en) * | 2002-06-11 | 2006-02-16 | Susumu Muto | Remedies for neurodegenerative diseases |
| DE60326082D1 (de) * | 2002-11-22 | 2009-03-19 | Lilly Co Eli | Modulatoren von vitamin d rezeptoren |
| EP1587906A2 (en) | 2003-01-10 | 2005-10-26 | Eli Lilly And Company | Vesicant treatment with phenyl-phenyl type vitamin d receptor modulators |
-
2004
- 2004-10-13 CA CA2542650A patent/CA2542650C/en not_active Expired - Fee Related
- 2004-10-13 WO PCT/US2004/033666 patent/WO2005037755A2/en not_active Ceased
- 2004-10-13 US US10/576,228 patent/US7863298B2/en not_active Expired - Fee Related
- 2004-10-13 EP EP04794900A patent/EP1675812B1/en not_active Expired - Lifetime
- 2004-10-13 AU AU2004282162A patent/AU2004282162B2/en not_active Ceased
- 2004-10-13 DE DE602004025261T patent/DE602004025261D1/de not_active Expired - Lifetime
- 2004-10-13 JP JP2006535596A patent/JP4782688B2/ja not_active Expired - Fee Related
- 2004-10-13 AT AT04794900T patent/ATE455749T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007509847A5 (https=) | ||
| JP5707131B2 (ja) | 抗炎症性化合物とその用途 | |
| US6503893B2 (en) | Method of treating hyperproliferative diseases using active vitamin D analogues | |
| RU2344123C2 (ru) | 3,4-дизамещенные циклобутен-1,2-дионы как лиганды схс-хемокинового рецептора | |
| CA2542650A1 (en) | Bridged ring structures as pharmaceutical agents | |
| WO2003045333A2 (en) | Treatment of hyperproliferative diseases using active vitamin d analogues | |
| AU2002322346A1 (en) | Method of treating hyperproliferative diseases using active vitamin D analogues | |
| JP2012153722A5 (https=) | ||
| RU2018122864A (ru) | Ингибиторы протеинкиназ, их способ получения и медицинское применение | |
| RU2014110623A (ru) | Пирролопиразиновые ингибиторы киназы | |
| EA023646B1 (ru) | Замещённые соли 2,3-дигидроимидазо[1,2-c]хиназолина | |
| US20170182001A1 (en) | Novel sesquiterpene derivatives and their use in inflammation or cancer treatment | |
| JP2014532730A5 (ja) | オピオイド受容体の調節物質およびそれを含む薬学的組成物 | |
| JP2010505865A (ja) | エーテル結合およびカルバメート結合を介する四置換ｎｄｇａ誘導体ならびにそれらの合成および薬学的使用 | |
| JP2006519788A (ja) | ビタミンｄ類似体およびそれらの治療利用 | |
| JP2021500334A5 (https=) | ||
| JP2004535439A5 (https=) | ||
| O’Boyle et al. | Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe | |
| Santra et al. | Two-Dimensional Organic Brick-Wall Layers as Hosts for the Inclusion and Study of Aromatics Ensembles: Acid− Pyridine and Acid− Carbonyl Synthons for Multicomponent Materials | |
| CN104717967A (zh) | 通过胆固醇生物合成抑制剂的雌激素受体β的诱导和治疗癌症的方法 | |
| RU2268054C2 (ru) | Сочетанная терапия с использованием пентафторбензолсульфонамидов | |
| JPWO2021065980A5 (https=) | ||
| US6822001B2 (en) | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents | |
| JP2017513810A5 (https=) | ||
| JP2013508320A5 (https=) |